A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer.
Mike MasonÓscar Lapuente-SantanaAnni S HalkolaWenyu WangRaghvendra MallXu XiaoJacob KaufmanJingxin FuJacob PfeilJineta BanerjeeVerena ChungHan ChangScott D ChasalowHung Ying LinRongrong ChaiThomas YuFrancesca FinotelloTuomas MirttiMikko I MäyränpääJie BaoEmmy W VerschurenEiman I AhmedMichele CeccarelliLance D MillerGianni MonacoWouter R L HendrickxShimaa SherifLin YangMing TangShengqing Stan GuWubing ZhangYi ZhangZexian ZengAvinash Das SahuYang LiuWenxian YangDavide BedognettiJing TangFederica EduatiTeemu D LaajalaWilliam J GeeseJustin GuinneyJoseph D SzustakowskiBenjamin G VincentDavid P CarbonePublished in: Journal of translational medicine (2024)
CheckMate 026; NCT02041533, registered January 22, 2014. CheckMate 227; NCT02477826, registered June 23, 2015.
Keyphrases